Liver Transplantation for Hepatocellular Carcinoma: An Update

View More View Less
  • 1 From the Department of Surgery, Section of Transplantation, UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, Nebraska.

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide and the most common primary hepatic malignancy. It arises on a background of hepatic cirrhosis in approximately 95% of the cases in the United States. A wide variety of treatment modalities have been applied in the treatment of HCC. Liver transplantation has emerged as the preferred treatment for patients with small HCC. Transplantation for patients whose tumors do not exceed the Milan criteria yields results equivalent to those of transplantation for non-HCC indications. Controversy now exists regarding the use of living donors, expansion of selection criteria, and role of adjuvant therapy.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Jean F. Botha, MD, Section of Transplantation, 983285 Nebraska Medical Center, Omaha, NE 68198-3285. E-mail: jbotha@unmc.edu
  • 1.

    Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985;202:401407.

  • 2.

    Ringe B, Wittekind C, Bechstein WO. The role of liver transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 1989;23(suppl):S104S109.

    • Search Google Scholar
    • Export Citation
  • 3.

    Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991;110:726735.

  • 4.

    Iwatsuki S, Starzl TE, Sheahan DG. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221229.

  • 5.

    Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270285.

    • Search Google Scholar
    • Export Citation
  • 6.

    Olthoff KM, Millis JM, Rosove MH. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990;125:12611268.

  • 7.

    Bismuth H, Chiche L, Adam R. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145151.

    • Search Google Scholar
    • Export Citation
  • 8.

    Mazzaferro V, Regalia E, Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693699.

    • Search Google Scholar
    • Export Citation
  • 9.

    Jonas S, Bechstein WO, Steinmuller T. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:10801086.

    • Search Google Scholar
    • Export Citation
  • 10.

    Llovet J, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:14341440.

    • Search Google Scholar
    • Export Citation
  • 11.

    Freeman RB, Wiesner RH, Edwards E. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:715.

  • 12.

    Befeler AS, Hyashi PH, Bisceglie AM. Liver transplantation for hepatocellular carinoma. Gastroenterology 2005;128:17521764.

  • 13.

    Yao FY, Ferrell L, Bass NM. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765774.

    • Search Google Scholar
    • Export Citation
  • 14.

    Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 2003;9:693696.

  • 15.

    Sauer P, Kraus TW, Schemmer P. Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the criteria? Transplantation 2005;80(1 Suppl):S105S108.

    • Search Google Scholar
    • Export Citation
  • 16.

    Lohe F, Angele MK, Gerbes AL. Tumor size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol 2005;31:994999.

    • Search Google Scholar
    • Export Citation
  • 17.

    Ismail T, Angrisani L, Gunson BK. Primary hepatic malignancy: the role of liver transplantation. Br J Surg 1990;77:983987.

  • 18.

    McPeake JR, O'Grady JG, Zaman S. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 1993;18:226234.

    • Search Google Scholar
    • Export Citation
  • 19.

    Selby R, Kadry Z, Carr B. Liver transplantation for hepatocellular carcinoma. World J Surg 1995;19:5358.

  • 20.

    Koo J, Fung K, Siu KF. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma. Cancer 1983;52:19521956.

    • Search Google Scholar
    • Export Citation
  • 21.

    Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced stage hepatocellular carcinoma. Hepatology 1995;21:403407.

    • Search Google Scholar
    • Export Citation
  • 22.

    Majno PE, Adam R, Bismuth H. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688703.

    • Search Google Scholar
    • Export Citation
  • 23.

    Perez Saborido B, Meneu JC, Moreno E. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 2005;190:383387.

    • Search Google Scholar
    • Export Citation
  • 24.

    Decaens T, Roudot-Thoraval F, Bresson-Hadni S. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005;11:767775.

    • Search Google Scholar
    • Export Citation
  • 25.

    Porrett PM, Peterman H, Rosen M. Lack of benefit of pretransplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 2006;12:665673.

    • Search Google Scholar
    • Export Citation
  • 26.

    Botha JF, Campos BD, Grant WJ. Should hepatocellular carcinoma be treated during the waiting list period? (abstract) Am J Transplant 2004;(suppl 8):Abstract #1389.

    • Search Google Scholar
    • Export Citation
  • 27.

    Yao FY, Hirose R, LaBerge JM. A prospective study on down-staging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005;11:15051514.

    • Search Google Scholar
    • Export Citation
  • 28.

    Yokoyama I, Carr B, Saitsu H. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991;68:20952100.

    • Search Google Scholar
    • Export Citation
  • 29.

    Frunam DA, Kiee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci USA 1992;89:3686.

    • Search Google Scholar
    • Export Citation
  • 30.

    Reizenstein P, Ogier C, Blomgren H. Cells responsible for tumor surveillance in man: effects of radiotherapy, chemotherapy, and biologic response modifiers. Adv Immun Cancer Ther 1985;1:128.

    • Search Google Scholar
    • Export Citation
  • 31.

    Azoulay D, Astarcioglu I, Bismuth H. Split-liver transplantation. The Paul Brousse policy. Ann Surg 1996;224:737746; discussion 746–748.

  • 32.

    Busuttil RW, Goss JA. Split liver transplantation. Ann Surg 1999;229:313321.

  • 33.

    Rogiers X, Malago M, Gawad K. In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg 1996;224:331339; discussion 339–341.

    • Search Google Scholar
    • Export Citation
  • 34.

    Cheng SJ, Pratt DS, Freeman RB Jr. Living-donor versus cadaveric liver transplantation for unresectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001;72:861868.

    • Search Google Scholar
    • Export Citation
  • 35.

    Gondolesi G, Munoz L, Matsumoto C. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg 2002;6:102107.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 42 23 3
PDF Downloads 35 27 2
EPUB Downloads 0 0 0